Bruce Cohen officially joined Xeraya in January 2016.

Bruce brings with him a wealth of business leadership experience in the areas of pharmaceuticals, medical technology and digital health, with strong business networks in the United States, where he has spent well over 30 years of management, marketing and business development experience in life sciences and high technology companies.

He was the founding President and CEO of three early stage biotechnology companies: Acacia Biosciences (acquired by Rosetta Inpharmatics), Cellerant Therapeutics and VitaPath Genetics. Bruce served as CFO at GeneSoft and has also held senior positions in business development and marketing at SEQUUS Pharmaceuticals and in the International, Management Services and Information Technology business units at Baxter International.

Bruce was the President and COO of ViTel International Inc., a pre-internet electronic messaging company. He also served as a management consultant with Monitor Company, working in the healthcare and high technology sectors. Bruce was a member of the founding team of the Tufts Veterinary School and a regional manager of the National Health Professions Placement Network.

Bruce holds a BA, cum laude (1975) and an MA (1980) from Tufts University; and an MBA with distinction (1982) from Harvard Business School, Harvard University.